CBridge Capital, a healthcare-focused investment firm, recently announced its investment in Beijing Anhejialier Technology Co., Ltd. ("Anhejialier"), a leading company in the field of ultrasonic knives. This investment represents CBridge Capital's strong recognition of Anhejialier's leadership in the field of ultrasonic knives and its long-term support and confidence in outstanding domestic brands.

CEC Capital served as the exclusive financial advisor in this transaction for Anhejialier.

Anhejialier holds a prominent position in the field of ultrasonic knives and is one of the few private enterprises capable of breaking the monopoly of imported brands in the Chinese market. Its products have been widely accepted by clinical users in China. In this highly competitive niche market, Anhejialier's self-developed ultrasonic knife system leads domestic brands in market share.